Nodal Recurrence is a Primary Driver of Early Relapse for Patients with Sentinel Lymph Node-Positive Melanoma in the Modern Therapeutic Era-Reference-Cited by-同舟云学术

Nodal Recurrence is a Primary Driver of Early Relapse for Patients with Sentinel Lymph Node-Positive Melanoma in the Modern Therapeutic Era

Published:2021-04-15 Issue:7 Volume:28 Page:3480-3489
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Mitra Devarati,Ologun Gabriel,Keung Emily Z.,Goepfert Ryan P.,Amaria Rodabe N.,Ross Merrick I.,Gershenwald Jeffrey E.,Lucci Anthony,Fisher Sarah B.,Davies Michael A.,Lee Jeffrey E.,Bishop Andrew J.,Farooqi Ahsan S.,Wargo Jennifer,Guadagnolo B. Ashleigh

Funder

NIH Clinical Center

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

https://link.springer.com/content/pdf/10.1245/s10434-021-09804-3.pdf

Reference26 articles.

1. Leiter U, Stadler R, Mauch C, et al. Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial. Lancet Oncol. 2016;17(6):757–67. https://doi.org/10.1016/S1470-2045(16)00141-8.

2. Leiter U, Stadler R, Mauch C, et al. Final analysis of DeCOG-SLT trial: no survival benefit for complete lymph node dissection in patients with melanoma with positive sentinel node. J Clin Oncol. 2019;37(32):3000–8. https://doi.org/10.1200/JCO.18.02306.

3. Faries MB, Thompson JF, Cochran AJ, et al. Completion dissection or observation for sentinel-node metastasis in melanoma. N Engl J Med. 2017;376(23):2211–22. https://doi.org/10.1056/NEJMoa1613210.